A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata

Last updated:
2026-07-18
Language and content disclaimer

The content and search results on this site are collected from or provided by third parties. As such some of the information may only be available in the language originally submitted by the sponsor of the trial. Learn more about the information on the search portal.

Linking to Non-Government of Canada Websites

Links to websites not under the control of the Government of Canada, including those to our social media accounts, and to clinical trial records in international registries are provided solely for the convenience of our website visitors. We are not responsible for the accuracy, currency or reliability of the content of such websites. The Government of Canada does not offer any guarantee in that regard and is not responsible for the information found through these links, nor does it endorse the sites and their content.

Visitors should also be aware that information offered by non-Government of Canada sites to which this website links is not subject to the Privacy Act or the Official Languages Act and may not be accessible to persons with disabilities. The information offered may be available only in the language(s) used by the sites in question. With respect to privacy, visitors should research the privacy policies of these non-government websites before providing personal information.

View trial details

Overview

Official protocol title:

A PHASE 3, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY, SAFETY, AND PHARMACOKINETICS OF BARICITINIB IN CHILDREN FROM 6 YEARS TO LESS THAN 18 YEARS OF AGE WITH ALOPECIA AREATA

Intervention/treatment:
BARICITINIB (LY3009104)
Medical condition:
ALOPECIA AREATA
Protocol code:
I4V-MC-JAIO
Control number:
275296
Status:
Recruiting
Approved:
June 15, 2023
Trial phase:
Phase 3
For more information:
ClinicalTrials.gov - NCT05723198
This is an external link. The information is not authorized by the Government of Canada.

Eligibility

Sex: ALL
Age
6 Years to 17 Years
Accepts healthy volunteers: No

Contacts and locations

Contact
Name
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or
Role
CONTACT
Phone:
1-317-615-4559
Name
Physicians interested in becoming principal investigators please contact
Role
CONTACT
Sponsor
ELI LILLY CANADA INC

Locations

Dermatology Research Institute
Calgary, T2J 7E1
Recruiting
Role
CONTACT
Phone:
4032633376
Name
Vimal Prajapati
Role
PRINCIPAL_INVESTIGATOR
Dr. Chih-ho Hong Medical Inc.
Surrey, V3R 6A7
Recruiting
Role
CONTACT
Phone:
604-953-1333
Name
Gurbir Dhadwal
Role
PRINCIPAL_INVESTIGATOR
Lynderm Research Inc.
Markham, L3P 1X2
Recruiting
Role
CONTACT
Phone:
905-471-8011
Name
Charles Lynde
Role
PRINCIPAL_INVESTIGATOR
Research Toronto
Toronto, M4W 2N2
Recruiting
Role
CONTACT
Phone:
416-962-0123
Name
Sameh Hanna
Role
PRINCIPAL_INVESTIGATOR
Skin Health
Cobourg, K9A 0Z4
Recruiting
Role
CONTACT
Phone:
(289) 252-1856
Name
Melinda Gooderham
Role
PRINCIPAL_INVESTIGATOR
Wiseman Dermatology Research Inc.
Winnipeg, R3M 3Z4
Recruiting
Role
CONTACT
Phone:
204-943-4922
Name
Marni Wiseman
Role
PRINCIPAL_INVESTIGATOR
Did you find what you were looking for?

Contacts and resources